AI-generated · cited to primary sources · not investment advice
Intuitive Surgical, Inc. - Common Stock (ISRG) Sep 2025 Filing Analysis
Does management do what it says?
Management successfully closed the acquisition of the da Vinci and Ion distribution businesses (abmedica, Abex, Excelencia Robótica) on March 1, 2026, within the guided H1 2026 timeline. (2 met across 2 tracked commitments)
“The Company expects to complete the transaction in the first half of 2026, subject to applicable regulatory approvals and customary closing conditions.”
The company has moved past the Q4 2025 adoption window and is now reporting under updated tax disclosure standards, including discussions on Pillar Two and the OBBBA. (2 met across 2 tracked commitments)
“The Company plans to adopt ASU 2023-09 during the fourth quarter of 2025 for its annual report using a prospective transition method”
While the 2025 full-year total is not explicitly restated, the Q1 2026 report confirms that capital expenditures increased in 2025 as planned to build infrastructure. (1 met, 1 in progress across 2 tracked commitments)
“We expect these capital investments to range between $625 million and $675 million in 2025, the majority of which will be facilities-related investments.”
See the full cited Management analysis of Intuitive Surgical, Inc. - Common Stock
How durable is the business?
Systems revenue grew significantly by 33%, aided by the launch of the next-generation da Vinci 5 platform and higher average selling prices (ASPs). (4 expanding)
“Systems revenue increased by 33% to $590 million for the three months ended September 30, 2025... driven by an increase in da Vinci 5 system placements.”
International revenue grew 20%, with particular strength in India, South Korea, and Brazil, though its share of total revenue dipped slightly to 31%. (1 expanding)
“The third quarter 2025 OUS da Vinci procedure growth was approximately 24%... driven by several markets with particular strength in India, South Korea, and Brazil.”
See the full cited Business Model analysis of Intuitive Surgical, Inc. - Common Stock
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.